| Date | Description |
|---|
| 2024-04-19 |
delete career_pages_linkeddomain paylocity.com |
| 2024-04-19 |
delete investor_pages_linkeddomain webcasts.com |
| 2024-04-19 |
insert investor_pages_linkeddomain open-exchange.net |
| 2024-03-18 |
delete source_ip 69.63.141.106 |
| 2024-03-18 |
insert career_pages_linkeddomain paylocity.com |
| 2024-03-18 |
insert source_ip 64.19.220.132 |
| 2023-07-26 |
delete cfo Ben Hohl |
| 2023-07-26 |
delete otherexecutives Andy J. Schwab |
| 2023-07-26 |
insert chieflegalofficer Galya Blachman |
| 2023-07-26 |
insert otherexecutives Galya Blachman |
| 2023-07-26 |
delete associated_investor Bay City Capital |
| 2023-07-26 |
delete person Andy J. Schwab |
| 2023-07-26 |
insert person Galya Blachman |
| 2023-07-26 |
update person_title Ben Hohl: Chief Financial Officer => Chief Financial Officer, and Head of Corporate Development |
| 2023-06-25 |
insert investor_pages_linkeddomain webcasts.com |
| 2023-06-25 |
insert investor_pages_linkeddomain wsw.com |
| 2023-04-08 |
delete general_emails in..@cormorant-asset.com |
| 2023-04-08 |
delete email in..@cormorant-asset.com |
| 2023-03-07 |
insert investorrelations_emails ir@enliventherapeutics.com |
| 2023-03-07 |
insert otherexecutives Rahul Ballal |
| 2023-03-07 |
insert publicrelations_emails me..@enliventherapeutics.com |
| 2023-03-07 |
insert associated_investor Versant Ventures |
| 2023-03-07 |
insert email ir@enliventherapeutics.com |
| 2023-03-07 |
insert email me..@enliventherapeutics.com |
| 2023-03-07 |
insert person Rahul Ballal |
| 2023-03-07 |
update person_description Andy Phillips => Andrew Phillips |